Medication that can protect humans against nuclear radiation has been developed by Jewish-American scientists in cooperation with a researcher and investors from Israel. The full story behind the dramatic discovery will be published in Yedioth Ahronoth’s weekend edition.
The ground-breaking medication, developed by Professor Andrei Gudkov – Chief Scientific Officer at Cleveland BioLabs – may have far-reaching implications on the balance of power in the world, as states capable of providing their citizens with protection against radiation will enjoy a significant strategic advantage vis-à-vis their rivals.
For Israel, the discovery marks a particularly dramatic development that could deeply affect the main issue on the defense establishment’s agenda: Protection against a nuclear attack by Iran or against “dirty bomb” attacks by terror groups.
Gudkov’s discovery may also have immense implications for cancer patients by enabling doctors to better protect patients against radiation. Should the new medication enable cancer patients to be treated with more powerful radiation, our ability to fight the disease could greatly improve.
Read the full story here.
The implications for the world are enormous. Victims of a Radiological attack could be effectively treated for the effects of Radiation Sickness, thus the terror effect of such an attack would be minimized.
Countries that don’t have access to this drug would be at a disadvantage. Countries that threaten nations with nuclear attack who have this drug in their possession are neutralized. In effect, this drug silences Kim Jong Il of North Korea. For although he has a nuclear weapon, with this drug available, the short and long term effects upon the human body is no longer a major worry.
The FDA is expected to approve this drug within a few years. Hope for cancer patients and for the rest of us who worry not if but when some nutcase or terror group gets a hold of nuclear material and tries to destroy a city with it.